DK0923606T3 - Antigent fusionsprotein med GALALPHA1,3GAL epitoper - Google Patents

Antigent fusionsprotein med GALALPHA1,3GAL epitoper

Info

Publication number
DK0923606T3
DK0923606T3 DK98912863T DK98912863T DK0923606T3 DK 0923606 T3 DK0923606 T3 DK 0923606T3 DK 98912863 T DK98912863 T DK 98912863T DK 98912863 T DK98912863 T DK 98912863T DK 0923606 T3 DK0923606 T3 DK 0923606T3
Authority
DK
Denmark
Prior art keywords
polypeptide
galalpha1
fusion protein
plasma
blood
Prior art date
Application number
DK98912863T
Other languages
Danish (da)
English (en)
Inventor
Jan Holgersson
Jining Liu
Original Assignee
Absorber Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absorber Ab filed Critical Absorber Ab
Application granted granted Critical
Publication of DK0923606T3 publication Critical patent/DK0923606T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98912863T 1997-03-26 1998-03-26 Antigent fusionsprotein med GALALPHA1,3GAL epitoper DK0923606T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701127A SE9701127D0 (sv) 1997-03-26 1997-03-26 Antigenic fusionprotein carrying GALal, 3GAL epitopes

Publications (1)

Publication Number Publication Date
DK0923606T3 true DK0923606T3 (da) 2006-05-22

Family

ID=20406335

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912863T DK0923606T3 (da) 1997-03-26 1998-03-26 Antigent fusionsprotein med GALALPHA1,3GAL epitoper

Country Status (12)

Country Link
US (3) US6943239B2 (sv)
EP (2) EP1700868A3 (sv)
JP (1) JP4099239B2 (sv)
AT (1) ATE315047T1 (sv)
AU (1) AU751760B2 (sv)
BR (1) BR9804826A (sv)
CA (1) CA2255765A1 (sv)
DE (1) DE69833106T2 (sv)
DK (1) DK0923606T3 (sv)
ES (1) ES2258297T3 (sv)
SE (1) SE9701127D0 (sv)
WO (1) WO1998042750A1 (sv)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7355017B2 (en) 2001-07-20 2008-04-08 Absorber Ab Blood group antigen fusion polypeptides and methods of use thereof
JP2005532793A (ja) * 2002-04-22 2005-11-04 レコファーマ アーベー 微生物付着を阻害するための融合ポリペプチドおよび方法
ATE551069T1 (de) * 2002-04-22 2012-04-15 Recopharma Ab Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
JP5183010B2 (ja) 2002-05-16 2013-04-17 グリコミメティクス， インコーポレイテッド セレクチンによって媒介される機能を阻害するための化合物および方法
CA2490703A1 (en) * 2002-07-03 2004-01-15 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
AU2003263411B8 (en) * 2002-08-09 2011-04-14 Recopharma Ab Mucin-Immunoglobulin fusion proteins
US20050076759A1 (en) * 2003-10-08 2005-04-14 Brian Westfall Linear saw with stab-cut bevel capability
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
US7459523B2 (en) * 2003-11-12 2008-12-02 Wisconsin Alumni Research Foundation Equine P-selectin glycoprotein ligand-1 and uses thereof
WO2005054264A2 (en) * 2003-11-19 2005-06-16 Glycomimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
EP1763533B1 (en) * 2003-11-19 2008-01-09 GlycoMimetics, Inc. Specific antagonist for both e- and p-selectins
EP1782838A4 (en) * 2004-06-23 2007-08-01 Japan Science & Tech Agency INHIBITION OF INFILTRATION AND AGENT TAKING CELLS
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
EP1928892B1 (en) * 2005-08-09 2011-10-12 GlycoMimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
CN101287741B (zh) * 2005-09-02 2014-05-07 糖模拟物有限公司 异型双功能全选择素抑制剂
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
CA2635011A1 (en) * 2006-01-26 2007-11-22 Recopharma Ab Use of sialylated fusion polypeptides for inhibition of oculotropic viruses
US20070178447A1 (en) * 2006-01-31 2007-08-02 Bethyl Laboratories, Inc. Method for decreasing interference in results of immunochemical methods
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
EP2074132B1 (en) 2006-10-12 2013-05-15 GlycoMimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
US7998486B2 (en) 2006-10-25 2011-08-16 Newlink Genetics Corporation Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
AU2008216794A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and N-acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) * 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
ES2426784T3 (es) * 2008-06-13 2013-10-25 Glycomimetics, Inc. Tratamiento de cánceres de la sangre usando compuestos glicomiméticos seleccionados
AU2010241807B2 (en) 2009-05-01 2014-08-14 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
US20120165272A1 (en) * 2010-12-21 2012-06-28 Recopharma Ab Tear Substitutes
US9109002B2 (en) 2011-12-22 2015-08-18 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
ES2668045T3 (es) 2012-12-07 2018-05-16 Glycomimetics, Inc. Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
ES2754549T3 (es) 2014-12-03 2020-04-20 Glycomimetics Inc Inhibidores heterobifuncionales de E-selectinas y receptores de quimioquinas CXCR4
EP3405473A1 (en) 2016-01-22 2018-11-28 GlycoMimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
EP3522931A1 (en) 2016-10-07 2019-08-14 GlycoMimetics, Inc. Highly potent multimeric e-selectin antagonists
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
JP7275131B2 (ja) 2017-11-30 2023-05-17 グリコミメティクス， インコーポレイテッド 骨髄浸潤リンパ球を動員する方法、およびその使用
EP3732186A1 (en) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
WO2019241386A1 (en) * 2018-06-12 2019-12-19 Rush University Medical Center Methods for enhanced endothelialization of implanted material
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3722375B2 (ja) * 1991-06-27 2005-11-30 ブリストル−マイヤーズ スクイブ カンパニー Ｃｔｌａ４レセプター、それを含有する融合タンパク質およびそれらの使用
JPH08502886A (ja) * 1992-10-23 1996-04-02 ジェネティックス・インスティテュート・インコーポレイテッド 新規ｐ−セレクチンリガンド蛋白質
JP4038236B2 (ja) * 1993-03-16 2008-01-23 オースチン・リサーチ・インスティテュート 異種移植治療におけるブタＧａ１α（１，３）ガラクトシルトランスフェラーゼの使用
GB9517758D0 (en) * 1995-08-31 1995-11-01 Imutran Ltd Compositions and their uses

Also Published As

Publication number Publication date
BR9804826A (pt) 2000-01-25
EP0923606B1 (en) 2006-01-04
JP2000511782A (ja) 2000-09-12
AU6755198A (en) 1998-10-20
US6943239B2 (en) 2005-09-13
US20020028205A1 (en) 2002-03-07
US20090286963A1 (en) 2009-11-19
DE69833106T2 (de) 2006-08-31
CA2255765A1 (en) 1998-10-01
DE69833106D1 (de) 2006-03-30
ES2258297T3 (es) 2006-08-16
ATE315047T1 (de) 2006-02-15
SE9701127D0 (sv) 1997-03-26
US20050255099A1 (en) 2005-11-17
EP0923606A1 (en) 1999-06-23
JP4099239B2 (ja) 2008-06-11
EP1700868A2 (en) 2006-09-13
AU751760B2 (en) 2002-08-29
WO1998042750A1 (en) 1998-10-01
EP1700868A3 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
DK0923606T3 (da) Antigent fusionsprotein med GALALPHA1,3GAL epitoper
KR910002897A (ko) 에리트로포이에틴(epo)펩타이드 및 이에 대한 항체
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
ES2087323T3 (es) Metodo para producir peptidos exentos de cisteina.
BR9506059A (pt) Proteinas envelopes purificadas de virus c para uso de diagnóstico e terapêutico
SE9304060D0 (sv) Sätt att selektera specifika bakteriofager
ATE192192T1 (de) Stress-proteine epitopen
ATE320448T1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
KR960022559A (ko) 슈도모나스 에루지노사 막 단백질로부터 유도된 면역원성 하이브리드 단백질 OprF-Oprl
DE69227041T2 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
ATE230020T1 (de) Katalytische antikörperkomponente
DK0530447T3 (da) Fremgangsmåde til rensning af IgG-monoklonale antistoffer
KR880700823A (ko) 사이토메갈로 바이러스에 대한 사람.모노클로날 항체와 그 제조방법
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
AU2002363465A8 (en) Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
AU2707992A (en) Monoclonal antibodies to hepatitis c virus
ATE207935T1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
AU5398898A (en) Recombinant fusion proteins of the porcine reproductive and respiratory syndrome virus (PRRSV) and its use in diagnosis
DK329789D0 (da) Monoklonalt antistof
DE68919553T2 (de) Rekombinantes Treponema hyodysenteriae-Antigen und seine Verwendungen.
EP1734054A3 (en) Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same